Cargando…

Role of artificial intelligence in peptide vaccine design against RNA viruses

RNA viruses have high rate of replication and mutation that help them adapt and change according to their environmental conditions. Many viral mutants are the cause of various severe and lethal diseases. Vaccines, on the other hand have the capacity to protect us from infectious diseases by elicitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Eileena, Mohanty, Anima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536498/
https://www.ncbi.nlm.nih.gov/pubmed/34722851
http://dx.doi.org/10.1016/j.imu.2021.100768
_version_ 1784588019381043200
author Mohanty, Eileena
Mohanty, Anima
author_facet Mohanty, Eileena
Mohanty, Anima
author_sort Mohanty, Eileena
collection PubMed
description RNA viruses have high rate of replication and mutation that help them adapt and change according to their environmental conditions. Many viral mutants are the cause of various severe and lethal diseases. Vaccines, on the other hand have the capacity to protect us from infectious diseases by eliciting antibody or cell-mediated immune responses that are pathogen-specific. While there are a few reviews pertaining to the use of artificial intelligence (AI) for SARS-COV-2 vaccine development, none focus on peptide vaccination for RNA viruses and the important role played by AI in it. Peptide vaccine which is slowly coming to be recognized as a safe and effective vaccination strategy has the capacity to overcome the mutant escape problem which is also being currently faced by SARS-COV-2 vaccines in circulation.Here we review the present scenario of peptide vaccines which are developed using mathematical and computational statistics methods to prevent the spread of disease caused by RNA viruses. We also focus on the importance and current stage of AI and mathematical evolutionary modeling using machine learning tools in the establishment of these new peptide vaccines for the control of viral disease.
format Online
Article
Text
id pubmed-8536498
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-85364982021-10-25 Role of artificial intelligence in peptide vaccine design against RNA viruses Mohanty, Eileena Mohanty, Anima Inform Med Unlocked Article RNA viruses have high rate of replication and mutation that help them adapt and change according to their environmental conditions. Many viral mutants are the cause of various severe and lethal diseases. Vaccines, on the other hand have the capacity to protect us from infectious diseases by eliciting antibody or cell-mediated immune responses that are pathogen-specific. While there are a few reviews pertaining to the use of artificial intelligence (AI) for SARS-COV-2 vaccine development, none focus on peptide vaccination for RNA viruses and the important role played by AI in it. Peptide vaccine which is slowly coming to be recognized as a safe and effective vaccination strategy has the capacity to overcome the mutant escape problem which is also being currently faced by SARS-COV-2 vaccines in circulation.Here we review the present scenario of peptide vaccines which are developed using mathematical and computational statistics methods to prevent the spread of disease caused by RNA viruses. We also focus on the importance and current stage of AI and mathematical evolutionary modeling using machine learning tools in the establishment of these new peptide vaccines for the control of viral disease. The Authors. Published by Elsevier Ltd. 2021 2021-10-23 /pmc/articles/PMC8536498/ /pubmed/34722851 http://dx.doi.org/10.1016/j.imu.2021.100768 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mohanty, Eileena
Mohanty, Anima
Role of artificial intelligence in peptide vaccine design against RNA viruses
title Role of artificial intelligence in peptide vaccine design against RNA viruses
title_full Role of artificial intelligence in peptide vaccine design against RNA viruses
title_fullStr Role of artificial intelligence in peptide vaccine design against RNA viruses
title_full_unstemmed Role of artificial intelligence in peptide vaccine design against RNA viruses
title_short Role of artificial intelligence in peptide vaccine design against RNA viruses
title_sort role of artificial intelligence in peptide vaccine design against rna viruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536498/
https://www.ncbi.nlm.nih.gov/pubmed/34722851
http://dx.doi.org/10.1016/j.imu.2021.100768
work_keys_str_mv AT mohantyeileena roleofartificialintelligenceinpeptidevaccinedesignagainstrnaviruses
AT mohantyanima roleofartificialintelligenceinpeptidevaccinedesignagainstrnaviruses